Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH1243598427
Mon, 14.09.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Bond
Sandoz issues EUR 500 million bond 14.09.2026 / 17:40 CET/CEST
MEDIA RELEASENOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN
Bond issuance with principal amount of EUR 500 million and 12 years maturity
Proceeds from bond issuance will be used for general corpo [ … ]
Tue, 08.09.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
New facility will expand manufacturing capacity, adding disposable fed-batch technology and further strengthening in-house biosimilar manufacturing and supply network in Europe
Disposable fed-batch technology will complement existing high-volume and continuous [ … ]
Tue, 08.09.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
Basel, 8 September 2026 - Sandoz (SIX:SDZ / OTCQX:SDZNY), the global leader in affordable medicines, today hosts its Capital Markets Day for investors and analysts. The event will focus on Bio100, the Sandoz goal to maximise value in its golden decade for biosi [ … ]
Wed, 05.08.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
Basel, 5 August 2026. Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today presents its financial results for the first half of 2026 and net-sales performance for the second quarter of 2026.
H1 2026 RESULTS
H1 net sales up by 5% at [ … ]
Mon, 03.08.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
When completed, settlement with 43 US states and territories would mean no remaining US federal or state governmental claims
Separate indirect reseller settlement resolves all remaining class-action litigation related to this matter
No impact on full-year 2026 g [ … ]
Wed, 29.07.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
Sandoz has commercial rights in USD 1.8 billion GLP-1 local market; positioned for launch in second half of 2026
More than 16.5 million Brazilians live with diabetes; disease remains key public health challenge in Brazil
Potential to expand patient access to hig [ … ]
Wed, 15.07.2026
Sandoz Group AG
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
Pascal Bouye appointed President, Generics Manufacturing & Supply; Glenn Gerecke takes on new role within Sandoz
North America President Keren Haruvi to oversee global M&A activities, in addition to current responsibilities
Transformation & Growth He [ … ]
Thu, 09.07.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Regulatory Admission
Sandoz moves up Swiss equity rankings to join premier Swiss Market Index 09.07.2026 / 07:00 CET/CEST
MEDIA RELEASE
Basel, 9 July 2026 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in affordable medicines, today announces that it will be included in the Swiss Market Ind [ … ]
Wed, 17.06.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Expansion
Sandoz steps up in-house biosimilar capabilities, opening state-of-the-art development centre to capture ‘golden decade’ opportunity 17.06.2026 / 07:00 CET/CEST
MEDIA RELEASE
Marking 20 years since launch of world’s first biosimilar, Sandoz opens new biosimilar development centre in L [ … ]
Fri, 15.05.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Regulatory Approval
Sandoz confirms European Commission approval for biosimilars Bysumlog® (insulin lispro) and Dazparda® (insulin aspart), strengthening position in diabetes 15.05.2026 / 13:00 CET/CEST
MEDIA RELEASE
Biosimilars Bysumlog® (insulin lispro) and Dazparda® (insulin aspart) approve [ … ]
